AngioConsult and Harrison Bay Life Sciences form unique partnership to defy challenges in times of the pandemic

Chattanooga/Speyer, October 14, 2020 – AngioConsult, a healthcare consultancy that has extensive experience in commercializing novel software technologies, announces a partnership with Harrison Bay Life Sciences (“HBLS”) to bring the new remote procedure support technology, ENVISIMED™, to the European market. HBLS is a medical device commercialization partner, bringing innovative medical products and services to the US-patient population. The two companies have the same mission and combine strengths to bring innovations to the patient.

Envisimed, a one-of-a-kind zero latency remote procedural support platform, enables users to interact and collaborate anywhere in the world without the delays that are often experienced with traditional browser-based collaboration tools. Envisimed is a proprietary cloud-based technology, providing required quality and natural interaction while enabling support for highly technical procedures, collaboration, and clinical trials. It allows for a natural interactive experience with a demonstrative capability, and unobtrusive visualization via a self-controlled 360° camera, while eliminating the necessity for physical presence and travel.

“The pandemic has impacted all of our professional and personal lives.”, states Ron Pirucki, Senior Partner at HBLS. “Safe distancing measures and travel restrictions now belong to our everyday life. Envisimed reduces the risk for medical vendors, support teams, hospital staff, patients, and their families by realizing reliable support detached from on-site visits.”

“Envisimed is accessible via a standard web browser and therefore available from anywhere in the world.”, adds Steve Redenbaugh, also Senior Partner at HBLS. “A broad variety of experts involved in medical device procedures and clinical trial support, can collaborate remotely with their peers and industry partners with reduced costs and increased number of supported cases.”

“The Envisimed technology is perfectly adapted to the current challenges and associated requirements for a functioning clinical routine with high acuity medical device procedures.”, comments Benjamin Rieck, CEO of AngioConsult. “We are proud to have formed such a great partnership with HBLS, bringing a technology into the European market which can really impact the way clinical support and training programs are done in the future.”

AngioConsult serves as a distribution partner for Envisimed in Europe while HBLS continues to handle sales in the United States and the remainder of the globe.

AngioConsult GmbH
Heydenreichstr. 5
67346 Speyer
GERMANY

Press contact:
Melanie Braun
Email: info@angioconsult.de

About AngioConsult GmbH:
AngioConsult is a Germany-based company specialized in the cardiovascular sector with three corporate branches: Healthcare IT, Business & Therapy Development, and Training & Innovation. In this way, AngioConsult addresses all challenges on the path from patent to commerce by combining product management, sales organization and training programs within one company. Website: www.angioconsult.de

About Harrison Bay Life Sciences:
HBLS’s unique infrastructure and experienced team provide medical device startup companies with everything they need to successfully achieve and maintain profitability throughout a product’s lifecycle. HBLS guides products through market analysis and market development; clinical trials and FDA approval; market entry and promotion; logistics, delivery, and inventory management; while providing exceptional clinical support. Website: www.hblifesciences.com

This release was published on openPR.